OncoEthix Company
Oncoethix is a Swiss company founded in 2007 by former associates at Cvitkovic & Associes Consultants SA. The company's goal is to develop 3 to 5 new drugs for cancer treatment and seek pharmaceutical partners for funding and commercialization. The founders have a successful track record in bringing oncology leads to global markets. Oncoethix has in-licensed three promising cancer drug candidates, with two currently in clinical development. The company was initially financed by the founders and received a Series A financing of 3.7 million Swiss francs in 2009 from venture capital firms Index Ventures and Endeavour Vision.
Funding Status:
M&A
Industry:
PharmTech
Investors Number:
5
Number Of Exists:
Series B
Technology:
Anti-infective Drugs
Founded Date:
2007
Investor Type:
Company
Headquarters:
Lausanne, Vaud
Total Funding:
CHF22.2M
Last Funding Type:
Series B
Employee Number:
51-100
Investment Stage:
N/A